Transaction in Own Shares
Summary by AI BETAClose X
|
RNS |
23 July 2026 |
Mercia Asset Management PLC
("Mercia", the "Company" or the "Group")
Transaction in Own Shares
Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused private capital asset manager with over £2.2billion of assets under management, announces that it has made the following purchases of Ordinary shares in the capital of the Company ("Ordinary Shares") on the London Stock Exchange, pursuant to the Share Buyback Programme announced on 1 April 2026, for the period from 16 July 2026 to 22 July 2026 (the "Period").
|
Date of purchase: |
Number of Ordinary Shares repurchased: |
Highest price paid per Ordinary Share (p): |
Lowest price paid per Ordinary Share (p): |
Volume weighted average price paid (p) |
|
16-Jul-26 |
50,000 |
26.50 |
26.50 |
26.50 |
|
17-Jul-26 |
25,000 |
26.50 |
26.50 |
26.50 |
|
22-Jul-26 |
60,000 |
26.50 |
26.50 |
26.50 |
The Company intends to cancel the shares. Following the purchase, the number of Ordinary Shares in issue and admitted to trading on AIM will be 421,744,557 (excluding treasury shares), and the Company is holding 11,608,112 Ordinary Shares in treasury.
This figure of 421,744,557 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended, the schedule below contains detailed information about the purchases made by Canaccord Genuity Limited for the Period, on behalf of the Company, as part of the Share Buyback Programme on both an aggregate and individual trade basis:
Aggregate information:
|
Venue |
Volume Weighted Average Price (p) |
Aggregated Volume |
|
AIMX |
26.50 |
135,000 |
Individual transactions:
|
Date of Transaction: |
Volume |
Price per Ordinary Share (p) |
Transaction Time |
Trading Venue |
Transaction Reference |
|
16-Jul-26 |
50,000 |
26.50 |
15:29:35 |
AIMX |
00110889481TRLO1 |
|
17-Jul-26 |
25,000 |
26.50 |
13:21:45 |
AIMX |
00110925620TRLO1 |
|
22-Jul-26 |
60,000 |
26.50 |
09:01:49 |
AIMX |
00111043649TRLO1 |
- Ends -
For further information, please contact:
Mercia Asset Management PLC
|
Mark Payton, Chief Executive Officer |
|
|
Martin Glanfield, Chief Financial Officer |
|
|
+44 (0)330 223 1430 |
|
|
|
|
|
Canaccord Genuity Limited (NOMAD and Joint Broker) |
|
|
Simon Bridges, Emma Gabriel, Harry Rees |
+44 (0)20 7523 8000 |
|
|
|
|
Singer Capital Markets (Joint Broker) |
|
|
Charles Leigh-Pemberton |
+44 (0)20 7496 3000 |
|
|
|
|
Cardew Group (PR Adviser) |
|
|
Tania Wild, Luke Bramwell |
|
|
+44 (0)20 7930 0777 |
About Mercia Asset Management PLC
Mercia is a private capital asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of venture, development capital, property finance and proprietary capital: the Group's 'Complete Connected Capital'.
The Group has a strong UK footprint through its 11 regional offices, extensive local adviser and personal networks, and university partnerships, providing it with access to high-quality deal flow.
Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 9 minutes ago Prudential
- 20 minutes ago Vanquis Banking Group 20
- 2 hours ago Frasers Group
- 2 hours ago Cavendish Financial
- 2 hours ago Diaceutics